In the last trading session, 8.51 million Silexion Therapeutics Corp (NASDAQ:SLXN) shares changed hands as the company’s beta touched -0.06. With the company’s per share price at $1.28 changed hands at -$0.03 or -2.29% during last session, the market valuation stood at $10.77M. SLXN’s last price was a discount, traded about -9432.81% off its 52-week high of $122.02. The share price had its 52-week low at $0.57, which suggests the last value was 55.47% up since then. When we look at Silexion Therapeutics Corp’s average trading volume, we note the 10-day average is 10.12 million shares, with the 3-month average coming to 14.23 million.

Silexion Therapeutics Corp (NASDAQ:SLXN) trade information

Instantly SLXN was in red as seen at the end of in last trading. With action -6.57%, the performance over the past five days has been red. The company’s shares are showing year-to-date downside of -36.32%, with the 5-day performance at -6.57% in the red. However, in the 30-day time frame, Silexion Therapeutics Corp (NASDAQ:SLXN) is 0.79% up. Looking at the short shares, we see there were 0.98 million shares sold at short interest cover period of 0.03 days.

SLXN Dividends

Silexion Therapeutics Corp is expected to release its next quarterly earnings report in April.

Silexion Therapeutics Corp (NASDAQ:SLXN)’s Major holders

If we look at who the major shareholders are, we find that insiders hold 13.25% of Silexion Therapeutics Corp shares while 14.80% of the shares are in the hands of institutional holders. The share float percentage for the stock currently stands at 17.06%.

With 587.0 shares estimated at $751.0 under it, the former controlled 0.03% of total outstanding shares.